Accès ouvert
2025
article
OpenAlex
Shatovisha Dey, Deep Pandya, Tammy Lo, Ryan Narbutas et autres
BACKGROUND: The average survival of advanced pancreatic cancer (APC) is 6-12 months with first-line chemotherapy. Only one-third receive second-line treatment. No early biomarker exists to guide chemotherapy efficacy before tumor progression occurs. Circulating small extracellular vesicles (sEVs) are a potential source of …
cz, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Richard C. Frank, Brian Shim, Tammy Lo, Deep Pandya et autres
OBJECTIVE: Pancreatic cancer (PC) has a high mortality rate due to the lack of early-stage detection strategies and lethality of advanced stage presentations. New-onset diabetes (NOD) in individuals ≥50 years old increases the risk 6- to 8-fold, making this group a target …
us
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Shatovisha Dey, Deep Pandya, Tammy Lo, Ryan Narbutas et autres
Abstract Advanced pancreatic cancer (APC) has an overall survival (OS) of 10 months with chemotherapy, yet some patients live only a few weeks whereas others up to two years. Novel early biomarkers are needed to guide prognostication and first-line chemotherapy efficacy, prior …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Claudia I. Henschke, Rowena Yip, Qi Sun, Pengfei Li et autres
us, cn
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Jonathan Kandiah, Tammy Lo, Dugho Jin, Landon Melchior et autres
INTRODUCTION: Pancreatic cancer (PC) screening recommendations have been based on studies performed solely at high-volume academic centers. To make PC screening more widely available, community-based efforts are essential. We implemented a prospective PC screening study in the community of Fairfield County, CT, …
us
(code pays fourni par la source)